News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
196,451 Results
Type
Article (30517)
Company Profile (36)
Press Release (165898)
Section
Business (51860)
Career Advice (1797)
Deals (10274)
Drug Delivery (121)
Drug Development (30945)
Employer Resources (191)
FDA (6549)
Job Trends (5869)
News (99381)
Policy (12673)
Tag
Academia (1624)
Alliances (14132)
Alzheimer's disease (747)
Antibody-drug conjugate (ADC) (83)
Approvals (6462)
Artificial intelligence (90)
Bankruptcy (112)
Best Places to Work (4590)
Biosimilars (76)
Breast cancer (90)
Cancer (633)
Cardiovascular disease (80)
Career advice (1507)
CAR-T (72)
Cell therapy (151)
Clinical research (23589)
Collaboration (219)
COVID-19 (2239)
Data (477)
Diabetes (108)
Diagnostics (2154)
Drug pricing (105)
Earnings (17138)
Employer resources (164)
Events (23769)
Executive appointments (108)
FDA (6760)
Funding (167)
Gene therapy (144)
GLP-1 (612)
Government (3207)
Healthcare (6640)
Infectious disease (2302)
Inflammatory bowel disease (83)
Interviews (353)
IPO (4093)
Job creations (1387)
Job search strategy (1227)
Layoffs (452)
Legal (2474)
Lung cancer (111)
Lymphoma (55)
Management (64)
Manufacturing (120)
Medical device (4197)
Medtech (4198)
Mergers & acquisitions (6215)
Metabolic disorders (379)
Neuroscience (942)
NextGen Class of 2024 (2622)
Non-profit (2055)
Northern California (513)
Obesity (247)
Opinion (213)
Patents (61)
People (15233)
Phase I (6619)
Phase II (10143)
Phase III (9596)
Pipeline (241)
Podcasts (96)
Policy (94)
Postmarket research (989)
Preclinical (2500)
Radiopharmaceuticals (71)
Rare diseases (176)
Real estate (1753)
Recruiting (72)
Regulatory (7983)
Research institute (1275)
Resumes & cover letters (283)
Southern California (427)
Startups (1384)
The Weekly (60)
United States (4307)
Vaccines (585)
Weight loss (227)
Date
Last 7 days (78)
Last 30 days (696)
Last 365 days (11877)
2024 (11857)
2023 (13132)
2022 (19544)
2021 (19800)
2020 (18735)
2019 (16785)
2018 (13465)
2017 (9748)
2016 (9081)
2015 (10011)
2014 (6913)
2013 (5501)
2012 (5782)
2011 (6065)
2010 (5335)
Location
Africa (451)
Asia (11337)
Australia (2093)
California (1134)
Canada (407)
China (92)
Connecticut (67)
Europe (30276)
Florida (139)
Illinois (127)
Indiana (93)
Maryland (240)
Massachusetts (796)
New Jersey (356)
New York (369)
North Carolina (175)
Northern California (513)
Ohio (55)
Pennsylvania (199)
South America (521)
Southern California (427)
Texas (140)
Washington State (112)
196,451 Results for "gi dynamics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting
December 18, 2024
·
2 min read
Press Releases
Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium
December 18, 2024
·
4 min read
Press Releases
Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data
December 23, 2024
·
12 min read
Genetown
GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET®
GI Dynamics, creator of the world’s first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®.
July 11, 2023
·
3 min read
Press Releases
Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers
December 18, 2024
·
5 min read
Press Releases
Genetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials
December 3, 2024
·
3 min read
Press Releases
Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
December 18, 2024
·
9 min read
Press Releases
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
December 18, 2024
·
5 min read
Business
Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update
Motus GI Holdings, Inc. reported its financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 14, 2024
·
7 min read
50% ORR: Impressive Clinical Trial Data for Irpagratinib Combined with Atezolizumab in Advanced Hepatocellular Carcinoma Stuns ESMO-GI Congress
Abbisko Therapeutics Co., Ltd. announced that it has presented new phase II clinical data of its highly selective FGFR4 inhibitor irpagratinib in combination with atezolizumab for the treatment of advanced hepatocellular carcinoma（HCC）at the 2024 ESMO-GI Congress.
June 27, 2024
·
3 min read
1 of 19,646
Next
